Jason Zhou

Jason Zhou was appointed to lead the newly created CR-CP Life Science Fund in 2019, which was sponsored by China Resources Group and Charoen Pokphand Group. Previously, he served in China Resource Group as the strategy director of the healthcare business sector since 2012. In addition to his management and operational responsibilities, Dr. Zhou intensively engaged in the investment deals in GenesisCare (served on the board) and Genscript.

Prior to China Resources, Jason worked in business operations in Norvatis, Pfizer, GSK, Takeda, Galderma, in multiple roles including sales marketing, medical advisory, and business development functions. Before entering the pharmaceutical industry, Jason practiced in Beijing Anzhen Hospital as a cardiovascular surgeon. Dr. Zhou graduated from the medical school of Peking University and earned his MBA in finance from the Chinese University of Hong Kong.